Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 104838 in Active Rheumatoid Arthritis
NCT00048321Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Jan 2002
- Primary completion
- Feb 2003
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 2
01
Overview
A Phase 2 trial of isis 104838 in rheumatoid arthritis (RA), sponsored by Ionis Pharmaceuticals. Started Jan 2002; status: completed.
02
Drugs
isis 104838
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00048321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048321.